News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Nutritional Health LTP Fund General Partner LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/13/2023 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Bought 1,082,251 shares
@ $2.31, valued at
$2.5M
Bought 1,082,251 shares
@ $2.31, valued at
$2.5M
Bought 3,246,753 shares
@ $2.31, valued at
$7.5M
|
|
| 08/15/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/14/2022 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 11/15/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/16/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/16/2021 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 02/04/2021 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Bought 37,143 shares
@ $15, valued at
$557.1k
Bought 9,285 shares
@ $15, valued at
$139.3k
Bought 37,143 shares
@ $15, valued at
$557.1k
Bought 46,429 shares
@ $15, valued at
$696.4k
|
|
| 11/25/2020 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Disposed of 3,587,820 shares
@ $0
Disposed of 642,180 shares
@ $0
Disposed of 966,234 shares
@ $0
Disposed of 1,186,310 shares
@ $0
Disposed of 1,481,481 shares
@ $0
Disposed of 43,154 shares
@ $0 |
|
| 07/01/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/08/2020 |
3
| Nutritional Health LTP Fund General Partner LLC (10% Owner) has filed a Form 3 on Kaleido Biosciences, Inc. |
| 06/28/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|